METABOLITE OF 1-DIMETHYLAMINO-3-(3-METHOXY-P HENYL)-2-METHYL-PENTANE-3-OL AND THE USE THEREOF IN THE TREATMENT OF URINARY INCONTINENCE

Details for Australian Patent Application No. 2003238398 (hide)

Owner GRUNENTHAL GMBH

Inventors HOLENZ, Jorg; BUSCHMANN, Helmut; ZIMMER, Oswald; CHRISTOPH, Thomas; KURTH, Burkhard

Pub. Number AU-A-2003238398

PCT Number PCT/EP03/05490

PCT Pub. Number WO2003/101440

Priority 102 24 624.6 30.05.02 DE

Filing date 26 May 2003

Wipo publication date 19 December 2003

International Classifications

A61K 031/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 031/185 - Acids

A61K 031/14 - Quaternary ammonium compounds, e.g. edrophonium, choline

A61K 031/7034

C07C 215/62 Compounds containing amino and hydroxy groups bound to the same carbon skeleton

C07C 215/72 Compounds containing amino and hydroxy groups bound to the same carbon skeleton

C07C 217/72 Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 102 24 624.6 30.05.02 DE

12 February 2004 Application Open to Public Inspection

  Published as AU-A-2003238398

17 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003238399-Use of levocetirizine for the treatment of persistent allergic rhinitis

2003238397-MEDICAMENT WITH DELAYED RELEASE OF THE ACTIVE SUBSTANCE, CONTAINING 1-DIMETHYLAMINO-3-(3-METHOXY-P HENYL)-2-METHYL-PENTAN-3-OL